Serum paraoxonase, TAS, TOS and ceruloplasmin in brucellosis

International Journal of Clinical and Experimental Medicine

Volumn 7, Issue 6, 2014, Pages 1592-1597

  Demirpençe, Özlem ^a   Sevim, Bünyamin ^a   Yildirim, Mustafa ^b   Nurlu, Nilhan Ayan ^c   Mert, Duygu ^b   Evliyaoǧlu, Osman ^a  

^a DICLE UNIVERSITY   (Turkey)

^b Ministry of Health Batman Regional Government Hospital   (Turkey)

^c ISTANBUL TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Brucella; Ceruloplasmin; Paraoxonase; Total antioxidant capacity; Total oxidant status

Indexed keywords

ARYLDIALKYLPHOSPHATASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BRUCELLOSIS; CERULOPLASMIN BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHELOMETRY; OXIDATIVE STRESS; SPECTROPHOTOMETRY;

EID: 84904057795     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Seleem MN, Boyle SM, Sriranganathan N. Brucellosis: A re-emerging zoonosis. Vet Microbiol 2010; 140: 392-8.
2. Franco MP, Mulder M, Gilman RH, Smits HL Human brucellosis. Lancet Infect Dis 2007; 7: 775-86.
3. Kocyigit A, Keles H, Selek S, Guzel S, Celik H, Erel O. Increased DNA damage and oxidative stress in patients with cutaneous leishmaniasis. Mutat Res 2005; 585: 71-8.
4. Eker A, Uzunca I, Tansel Ö, Birtane E. A patient with brucellar cervical spondylodiscitis complicated by epidural abscess. J Clin Neurosci 2011; 18: 428-30.
5. Hasan HR, Ghadhban JM, Abudal Kadhum ZI. Salivary ceruloplasmin ferroxidase & oxidase activities in celiac patients. Int J Biomed Sci 2012; 8: 163-70.
6. Zowczak M, Iskra M, Paszkowski J, Mańczak M, Torliński L, Wysocka E. Oxidase activity of ceruloplasmin and concentration of copper and zinc in serum of cancer patients. J Trace Elem Med Biol 2001; 15: 193-219.
7. Précourt LP, Amre D, Denis MC, Lavoie JC, Del-vin E, Seidman E, Levy E. The three-gene para-oxonase family: physiologic roles, action and regulation. Atherosclerosis 2011; 214: 20-36.
8. Vecka M, Jáchymová M, Vávrová L, Kodydková J, Macášek J, Urbánek M, Krechler T, Slabý A, Dušková J, Muravská A, Zák A. Paraoxonase-1 (PON1) status in pancreatic cancer: relation to clinical parameters. Folia Biol (Praha) 2012; 58: 231-7.
9. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004; 37: 112-9.
10. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Bio-chem 2005; 38: 1103-11.
11. Karaagac L, Koruk ST, Koruk I, Aksoy N. Decreasing oxidative stress in response to treatment in patients with brucellosis: could it be used to monitor treatment? Int J Infect Dis 2010; 15: 346-9.
12. Apostolou F, Gazi IF, Kostoula A, Tellis CC, Tsel-epis AD, Elisaf M, Liberopoulos EN. Liberopou-los. Persistence of an atherogenic lipid profle after treatment of acute infection with Brucel-la. J Lipid Res 2009; 50: 2532-9.
13. Gitlin JD. Transcriptional regulation of cerulo-plasmin gene expression during infammation. J Biol Chem 1988; 263: 6281-7.
14. Gutteridge JM, Winyard PG, Blake DR, Lunec J, Brailsford S, Halliwell B. The behaviour of cae-ruloplasmin in stored human extracellular fu-ids in relation to ferroxidase II activity, lipid peroxidation and phenanthroline-detectable copper. Biochem J 1985; 230: 517-23.
15. Hellman NE, Gitlin JD. Ceruloplasmin metabolism and function. Annu Rev Nutr 2002; 22: 439-58.
16. Van Campenhout A, Van Campenhout C, La-grou AR, Abrams P, Moorkens G, Van Gaal L, Manuel-y-Keenoy B. Impact of diabetes melli-tus on the relationships between iron-, infam-matory- and oxidative stress status. Diabetes Metab Res Rev 2006; 22: 444-54.
17. Fotiou K, Vaiopoulos G, Lilakos K, Giannopou-los A, Mandalenaki K, Marinos G, Koritsiadis G, Sourdis J, Konstantinidou E, Konstantopou-los K. Serum ceruloplasmin as a marker in prostate cancer. Minerva Urol Nefrol 2007; 59: 407-11.
18. Eser I, Ulas T, Kurkcuoglu IC, Aydogan H, Yalcin F, Sak ZH, Aydin MS, Hazar A, Demir ME, Aksoy N. Evaluation of ceruloplasmin levels in patients with pulmonary cystic echinococcus. Clin Ter 2013; 164: e89-92.
19. Goetting V, Lee KA, Woods L, Clemons KV, Stevens DA, Tell LA. Infammatory marker profles in an avian experimental model of aspergillo-sis. Med Mycol 2013; 51: 696-703.
20. Mermut G, Ozgenç O, Avci M, Olut AI, Oktem E, Genç VE, Ari A, Coskuner SA. Clinical, diagnostic and therapeutic approaches to complications of brucellosis: an experience of 12 years. Med Princ Pract 2012; 21: 46-50.
21. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004; 37: 112-9.
22. Usta M, Aras Z, Tas A. Oxidant and antioxidant parameters in patients with Brucella canis. Clin Biochem 2012; 45: 366-7.
23. Serefhanoglu K, Taskin A, Turan H, Timurkaynak FE, Arslan H, Erel O. Evaluation of oxidative status in patients with brucellosis. Braz J Infect Dis 2009; 13: 249-51.
24. Karaagac L, Koruk ST, Koruk I, Aksoy N. Decreasing oxidative stress in response to treatment in patients with brucellosis: could it be used to monitor treatment? Int J Infect Dis 2011; 15: 346-9.